Evidence map›Paper›PMID 41965377›Full record

ArticleNature communications2026

β2 adrenergic receptors orchestrate neutrophil demargination and recruitment to the ischemic heart following myocardial infarction.

Albert Dahdah, Krishna P Maremanda, Mathankumar Marimuthu, Ki Ho Park, Robert M Jaggers, Dipanjan Chattopadhyay, Wang Qiang, Nitin Nitin, Stavros Stavrakis, Tarun W Dasari and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Albert Dahdah *Section of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-9122-6990
Krishna P Maremanda *Section of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-8458-9785
Mathankumar MarimuthuSection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Ki Ho ParkDivision of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Robert M JaggersDivision of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Dipanjan ChattopadhyaySection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Wang QiangDivision of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Nitin NitinSection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Stavros StavrakisSection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Tarun W DasariSection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Viorel I ȘuicãProteomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.
Raluca M BoteanuProteomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.
Elena UyyProteomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.
Felicia AntoheProteomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.
Douglas G TilleyAging+ Cardiovascular Discover Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-9681-3377
Andrew J MurphyDivision of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7039-7777
Prabhakara R NagareddySection of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Prabhakara-nagareddy@ou.edu.

Funding

American Heart Association (American Heart Association, Inc.) TPA97002U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL137799U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL156856
6 · The paper itself

Abstract

Neutrophils rapidly accumulate in the heart after myocardial infarction (MI), yet bone marrow granulopoiesis peaks later, suggesting an alternative early source. Here we show in male mice that the first wave of neutrophils recruited to the ischemic heart arises from the vascular marginated pool rather than newly generated cells in the bone marrow or spleen. Using hematopoietic stem cell ablation, flow cytometry and proteomic analyses, we find that early MI-induced neutrophilia displays hallmarks of stress-induced demargination, a process in which adherent neutrophils are rapidly released into circulation. Pharmacological or genetic inhibition of norepinephrine synthesis or β-adrenergic receptor signaling in male mice suppresses neutrophil demargination and limits cardiac infiltration. Although sustained β-adrenergic blockade does not improve long-term outcomes, transient inhibition enhances cardiac remodeling and function. These findings identify stress-induced demargination as the dominant source of early post-MI neutrophils and suggest that temporally targeted β2-adrenergic modulation may help restrain acute inflammatory injury.

Indexed as

Myocardial InfarctionMyocardial IschemiaNeutrophil InfiltrationNeutrophilsReceptors, Adrenergic, beta-2AnimalsMaleMiceMice, Inbred C57BLMyocardiumNorepinephrineSignal TransductionNorepinephrineReceptors, Adrenergic, beta-2

Identifiers

PMID41965377
PMCPMC13246851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.